📖

Valproic Acid in PSP (NCT00385710)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-valproic-acid-psp-n
Related Entities
clinical-trials-valproic-acid-psp-nct00385710
Metadata
slugclinical-trials-valproic-acid-psp-nct00385710
entity_typeclinical
kg_node_idNone
Linked Artifacts (77)
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement65%
mentions🧪HDAC3-Selective Inhibition for Clock Reset65%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue60%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa60%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement58%
related🧪HDAC3-Selective Inhibition for Clock Reset58%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue54%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa54%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa50%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio50%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Epigenetic reprogramming in aging neurons50%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
related🧪Epigenetic Memory Erasure via TET2 Activation50%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
related🧪HSP90-Tau Disaggregation Complex Enhancement50%
related🧪Noradrenergic-Tau Propagation Blockade50%
related🧪Synaptic Vesicle Tau Capture Inhibition50%
related🧪Arginine Methylation Enhancement Therapy50%
related🧪SASP-Mediated Cholinergic Synapse Disruption50%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
related🧪Trans-Synaptic Adhesion Molecule Modulation50%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%